Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Walz

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
European Urology Oncology|May 18, 2019
Rely on Your Eyes or on Your Mind? How Magnetic Resonance Imaging Before First Biopsy Could Become FeasibleJochen Walz
European Urology|February 2, 2022
Re: Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients with Localized Prostate Cancer: Results from the FLAME Randomized Phase III TrialJochen Walz
European Urology|April 23, 2018
Re: Surveillance or Metastasis-directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II TrialJochen Walz
European Urology|October 3, 2017
The "PROMIS" of Magnetic Resonance Imaging Cost Effectiveness in Prostate Cancer Diagnosis?Jochen Walz
European Urology|November 1, 2018
What Needs To Be Done Before Prostate Magnetic Resonance Imaging Can Safely Be Applied in the General PopulationJochen Walz
European Urology|March 15, 2016
Words of Wisdom. Re: Comparison of MR/Ultrasound Fusion-Guided Biopsy With Ultrasound-guided Biopsy for the Diagnosis of Prostate CancerJochen Walz
European Urology Oncology|June 14, 2022
Better To Rule In or Rule Out Significant Prostate Cancer? The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography to Magnetic Resonance Imaging Diagnostic Pathways for Prostate CancerJochen Walz
European Urology|July 16, 2019
Let's Keep It at One Step at a Time: Why Biparametric Magnetic Resonance Imaging Is Not the Priority TodayJochen Walz
European Urology|May 12, 2020
Re: Prostate-specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-resistant Prostate CancerJochen Walz
Gland Surgery|May 19, 2020
Identifying the relevant population for neoadjuvant chemo-hormonal therapy combined with radical prostatectomyGéraldine Pignot, Jochen Walz
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
European Urology Oncology|May 18, 2019
Rely on Your Eyes or on Your Mind? How Magnetic Resonance Imaging Before First Biopsy Could Become FeasibleJochen Walz
European Urology|February 2, 2022
Re: Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients with Localized Prostate Cancer: Results from the FLAME Randomized Phase III TrialJochen Walz
European Urology|April 23, 2018
Re: Surveillance or Metastasis-directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II TrialJochen Walz
European Urology|October 3, 2017
The "PROMIS" of Magnetic Resonance Imaging Cost Effectiveness in Prostate Cancer Diagnosis?Jochen Walz
European Urology|November 1, 2018
What Needs To Be Done Before Prostate Magnetic Resonance Imaging Can Safely Be Applied in the General PopulationJochen Walz
European Urology|March 15, 2016
Words of Wisdom. Re: Comparison of MR/Ultrasound Fusion-Guided Biopsy With Ultrasound-guided Biopsy for the Diagnosis of Prostate CancerJochen Walz
European Urology Oncology|June 14, 2022
Better To Rule In or Rule Out Significant Prostate Cancer? The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography to Magnetic Resonance Imaging Diagnostic Pathways for Prostate CancerJochen Walz
European Urology|July 16, 2019
Let's Keep It at One Step at a Time: Why Biparametric Magnetic Resonance Imaging Is Not the Priority TodayJochen Walz
European Urology|May 12, 2020
Re: Prostate-specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-resistant Prostate CancerJochen Walz
Gland Surgery|May 19, 2020
Identifying the relevant population for neoadjuvant chemo-hormonal therapy combined with radical prostatectomyGéraldine Pignot, Jochen Walz
Pageof 22